Dongying Li

Ms. Dongying Li


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
KCKaiyu Cui
Kaiyu Cui
YWYang Weifeng
Yang Weifeng
SLShuang Liu
Shuang Liu
DLDongying Li
Dongying Li
LLLi Lu
Li Lu
YWYi Wang
Yi Wang
Methicillin-resistant Staphylococcus aureus (MRSA) has posed a severe global health threat. In this study, we screened an antibiotic and non-antibiotic combination that provides a viable strategy to solve this issue by broadening the antimicrobial spectrum. We found that chenodeoxycholic acid (CDCA) could synergistically act with carbapenem antibiotics to eradicate MRSA-related infections. This synergy specifically targets MRSA and was also validated using 25 clinical MRSA strains using time–kill analysis. We speculated that the underlying mechanism was associated with the interaction of penicillin-binding proteins (PBPs). As a result, the synergistic efficiency of CDCA with carbapenems targeting PBP1 was better than that of β-lactams targeting PBPs. Moreover, we showed that CDCA did not affect the expression level of PBPs, but sensitized MRSA to carbapenems by disrupting the cell membrane. In our study, we have revealed a novel synergistic combination of antibiotics and non-antibiotics to combat potential bacterial infections.

1 November 2013
Verified
Journal Article
Closed access
DLDongying Li
Dongying Li
XLXiao-Qian Liu
Xiao-Qian Liu
WFWei-Hong Feng
Wei-Hong Feng
ZWZhi-Min Wang
Zhi-Min Wang
HYHong Yi
Hong Yi
QMQing-Ju Meng
Qing-Ju Meng